University of Minnesota. Driven to Discover.
In addition, phase 2 trial of an adenovirus-based vaccine shows it to be safe and immunogenic though protection less than prolonged.
Ebola cropped up again in two of Guinea's districts that hadn't reported cases in about 50 days.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.